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Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, which accounts for
the cAMP-modulated chloride conductance of airway epithelial cells. CFTR also regulates other membrane proteins like the negative
regulation of the amiloride-sensitive epithelial sodium channel (ENaC). Mutations in the CFTR gene lead to hyperabsorption of
sodium chloride and a reduction in the periciliary salt and water content which leads to impaired mucociliary clearance. It seems
that a lack of functional CFTR leads to abnormal function of the NF-nB pathway in submucosal gland cells, causing an increased
production of pro-inflammatory cytokines and the chemokine IL-8, and a pro-inflammatory environment. CFTR is also expressed in
neutrophils and several neutrophil functions like cytokine production, migration, phagocytosis and apoptosis seem altered in CF. In
this review we describe the role of airway epithelium and blood neutrophils in the viscious circle of inflammation and infection
seen in CF.
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The hallmarks of the lung pathology in CF are
bacterial colonisation and infection of the airways
(particularly with Pseudomonas aeruginosa and Staph-
ylococcus aureus) and an apparently exaggerated, sus-
tained and extended inflammatory response, characterised
by influx of neutrophils and high concentrations of
interleukin-8 in bronchoalveolar lavage fluid (BALF)
[1–8]. Several pathophysiological mechanisms have been
postulated to explain the pulmonary infections and
inflammation. In this review we will focus on the role
of mutant CFTR on various aspects of the airway
epithelium including mucociliary clearance, submucosal
gland cell products and bacterial binding. We will
furthermore focus on the role of neutrophils in airway1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
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the ongoing inflammatory response.2. Defence mechanisms by airway epithelium
2.1. Mucociliary clearance
Airway epithelium is covered on its apical surface by a
thin liquid layer called the airway surface liquid (ASL).
The ASL is the first line of defence against inhaled
pathogens and is mandatory for effective mucociliary
clearance [9]. ASL is composed of a mucus gel and a
periciliary sol layer (PCL) [10] that are propelled upwards
by coordinated ciliary beating. The PCL of the ASL is an
aqueous solution with a height, equalling the height of
extended cilia (¨7 Am), and a relatively low viscosity
enabling effective ciliary beating and cell surface lubrica-
tion. The mucus layer is a gel-like aqueous layer in which
soluble compounds are mixed with mucus polymers ands 4 (2005) 15 – 23ed by Elsevier B.V. All rights reserved.
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glycoproteins, proteoglycans, defence molecules (like
lactoferrin, lysozyme and defensins), DNA, and actin.
The two major mucins present in human respiratory
mucosa are MUC5AC and MUC5B [11,12]. The diversity
of the carbohydrate side chains within the mucin gel
allows entrapment of a wide variety of particles, like
bacteria, for ultimate clearance from the airway [13].
Effective mucus transport requires a well-defined PCL
liquid layer and the capacity of the airway epithelium and
mucus layer to maintain the PCL layer at the appropriate
height [14]. The mucus layer has the propensity to swell and
shrink by accepting liquid from or donating liquid to the
PCL layer as needed [15]. The airway epithelium seems to
have the capacity to both absorb liquid from the PCL and to
secrete liquid into the PCL as necessary, a process that is
believed to be mediated by isotonic (100–150 mM NaCl)
volume transport [16–18]. Still relatively little is known
about this tightly regulated process such as: what are the
sensors of ASL volume and how is information transmitted
to the various effectors (ion channels) in the apical cell
membrane [15]. Under physiological conditions, the airway
epithelium defence system, by virtue of endogenously
produced antimicrobial peptides like lactoferrin and lyso-
zyme can suppress bacterial growth for 3 to 6 h [19], after
which bacteria are cleared from the airways by mucociliary
clearance within 6 h [13].
In CF, loss of CFTR function results in altered salt
transport of the airway epithelium. This has led to the
proposal of basically two hypotheses, addressing the
mechanism by which altered salt transport, associated with
the loss of CFTR, leads to a breakdown of lung defence
mechanisms in CF and to persistent endobronchial infec-
tions [20,21]. The first hypothesis is the isotonic ‘‘low
volume’’ hypothesis with resultant abnormalities in muco-
ciliary clearance. This hypothesis proposes that a lack of
CFTR inhibition of epithelium sodium channels (EnaC)
causes increased Na+ absorption. On top of this, mutant
CFTR also fails to initiate cAMP-dependent Cl secretion.
This causes an increased water absorption, leading to a
decreased volume of the PCL: components of the ASL (see
Fig. 1) [22,23]. The decrease in ASL volume also decreases
mucociliary clearance and causes mucus stasis. TheFig. 1. Hypothetical models on ASL dysregulatioconcentrated mucus adheres to the cell surface leading to
a reduced efficacy of mucociliary clearance by coughing.
The ciliated cells require an increased metabolic activity to
sustain the excessive salt and water absorption and this,
together with the accumulated mucus leads to hypoxia in
adherent mucus plaques near the epithelial cell surface
[24,25]. The combination of mucus plaques and mucus
hypoxia probably promotes the accumulation of bacteria.
The innate antimicrobial peptides present in the mucucs are
no longer able to control bacterial growth, and the formation
of bacterial biofilms can result in the acquisition of chronic
bacterial infection [26]. An important argument in the low
volume hypothesis is EnaC dysregulation. Several studies
have shown that CFTR functions as a regulator of ENaC
[27–30] but the exact molecular interaction between CFTR
and ENaC remains to be elucidated.
The second and opposite hypothesis is the ‘‘composi-
tional’’ hypothesis with hypertonic ASL salt concentrations
in CF, inactivating salt-sensitive antimicrobial peptides [31].
This hypothesis proposes that a lack of CFTR leads to
defective cellular chloride absorption, leading to an
increased Cl concentration of ASL in patients with CF.
This increased Cl concentration of ASL inactivates the
salt-sensitive antimicrobial peptides like defensins [31–33].
More recently studies in mouse-models on the ASL ionic
composition as well as studies in CF-patients however failed
to detect differences in ASL ionic composition between
normal and CF, i.e. both normal and CF ASL are isotonic
[34–36]. These results therefore would favour the isotonic
‘‘low volume’’ hypothesis but the ‘‘compositional’’ hypoth-
esis cannot be entirely refuted yet. It should be kept in mind
that there are significant technical limitations of collecting
and assaying ASL from the upper and lower airways and it
is not feasible yet to perform the necessary experiments in
vivo, in actual human airways.
2.2. Submucosal gland cell products
Serous cells secrete a variety of nonmucin products like
lysozyme, lactoferrin, secretory IgA, peroxidase and
protease inhibitors [38]. They also secrete several defen-
sins, salt-sensitive antimicrobial substances important in
airway defence [31,39,40]. CFTR is highly expressed in then in CF (see text for further explanation).
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serous cells are considered to be the primary defence cells
of the airway mucosa [38]. The presence of CFTR in the
secretory granules of serous cells [38] suggests that CFTR
contributes mechanistically to secretion of glycoproteins,
either by providing a regulated Cl conductance in
secretory granule membranes or by contributing to
cAMP-mediated secretory vesicle exocytosis. Loss of
CFTR function may lead to an alteration in the macro-
molecular composition of the serous cell secretions and
thereby also change mucus viscosity and may adversely
affect mucociliary clearance [13,37,42,43].
In CF the bronchial and tracheal gland cells show an
altered cytokine production profile with a significant
decrease of IL-10 content and a reduced ability of CF
epithelial cells (and CD4+ T-lymphocytes) to produce IL-
10 in response to inflammatory stimuli [44–46]. Further-
more there is a constitutive upregulation of the pro-
inflammatory chemokine IL-8 by CF airway epithelial cells
and an increased IL-8 mRNA expression in bronchial
epithelial cells in young CF-patients [44,47–52]. The
synthesis of all these pro-inflammatory cytokines and
chemokines elevated in CF is regulated by the transcription
factor nuclear factor-nB (NF-nB) [53]. In epithelial cell
lines derived from CF-patients, a higher and constitutiveFig. 2. Central role of NF-nB in signalling routes of inflammation receptors. Pathwactivation of NF-nB has been described [49,50,54]. It is
suggested that a lack of functional CFTR leads to
abnormal function of the NF-nB pathway [49,55]. It is
however also suggested that a decrease or absence in IL-10
locally, which is described in patients with CF [44,56],
causes increased expression of InB a/h kinases. InB a/h
kinases are required for NF-nB activation [49]. The
combination of reduced IL-10 and increased InB a/h
kinases may lead to uncontrolled NF-nB activation (see
also Fig. 2) [57].
2.3. Bacterial binding and colonozation
CFTR appears to play an indirect, but also a direct role
in the ability of CF pathogens like S. aureus, Haemophilus
influenzae and P. aeruginosa to bind to epithelial
membrane in cell culture systems [58–60]. The finding
that significant numbers of bacteria do not bind to
differentiated epithelia of native airway secretions [61,62]
but are bound to injured epithelia [63–66] suggest that
direct epithelial–bacterial cell interactions require ante-
cedent epithelial injury. Bacterial–epithelial adhesion may
be important once infection and inflammation have caused
epithelial injury but appears less likely to play a critical
role in the initiation of infection.ays/activities found to be upregulated in CF indicated by circled arrowheads.
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CFTR serves as a pattern recognition molecule for P.
aeruginosa lipopolysaccharide-core oligosaccharide.
Expression of mutant CFTR leads to a defective internal-
isation of P. aeruginosa and defective epithelial cell
phagocytosis of these bacteria [67–69]. The relative
importance of epithelial phagocytosis in innate immune
defense against P. aeruginosa is uncertain.
2.4. Neutrophils
Neutrophils are the major cellular players of the innate
immune system, both by phagocytosis of infectious agents
but also by their capacity to limit the growth of some
microbes. Both mechanisms serve to keep an infection
under control until adaptive (specific) immunological
responses can develop.
2.5. Priming
Neutrophils exist in a dormant (resting) state unless
they become activated. Over the last decade it has
become clear that this ‘‘all or nothing’’ scenario is too
simplistic and that various intermediate stages exist, such
as the primed state. Priming is a mechanism whereby
dormant neutrophils acquire a state of preactivation that
generates a more powerful response to microbial activity
[70]. In patients with CF, neutrophils show an increased
primed phenotype measured by expression of phagocyte
opsonin receptors, like complement receptor (CR)1
(CD35) and CR3 (CD11b), response capacity, even in
uninfected children with CF [71]. These data, which areFig. 3. Cellular and molecular interactions during neutrophil migration. Pathway
circled arrowheads. See text for further details.compatible with data from our own group [72], may
point towards CF as a disease with autoinflammatory
characteristics.
2.6. Cytokine and chemokine production
During an inflammatory response, chemotactic factors
of different origin and pro-inflammatory cytokines signal
the recruitment of neutrophils to sites of infection and/or
injury. Not only CF epithelial cells, but also CF neutrophils
display an abnormal release pattern of inflammatory
mediators. Blood neutrophils from patients with CF
constitutively secrete higher amounts of IL-8 and lower
amounts of the anti-inflammatory cytokine IL-1 receptor
antagonist (IL-1 RA) [73]. Spontaneous release of IL-8 and
IL-1 RA by CF airway neutrophils is even higher,
indicating a modification of the response by the local
environment [73]. The finding that spontaneous release of
IL-8 was significantly lower in airway neutrophils from
children with dyskinetic cilia syndrome however provides
support for a genetic component.
2.7. Migration
Neutrophil migration to the site of infection/inflammation
is a multistep process that consists of tethering (capture),
rolling, slow rolling, firm adhesion and transmigration (see
also Fig. 3) [74,75]. The initial event is caused by the
appearance of new adhesion molecules (E-selectin and P-
selectin (pre-stored in the Weibel-Palade bodies) on the
endothelium adjacent to the inflamed site. Expression of
these adhesion molecules is induced by inflammations/activities found to be upregulated or downregulated in CF indicated by
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bacterial lipopolysaccharide (LPS). In postcapillary venules,
the slow flow rate allows for a short transient interaction (or
tethering) between the neutrophil and the endothelium.
Neutrophils roll along microvascular walls via low affinity
interaction of selectins (like L-selectin (CD62L), present on
neutrophils and E-selectin on endothelial cells) with specific
endothelial carbohydrate ligands. This leads to the activation
of neutrophil-integrins (for example aMh2 (CD11b/CD18,
also known as CR3)) and subsequent firm adhesion to
intercellular adhesion molecules on the surface of activated
endothelial cells in postcapillary venules. Under the influence
of a locally generated chemotactic gradient and by diffusion
of chemoattractants from the infection site, neutrophils
penetrate the endothelial layer and migrate through con-
nective tissue to sites of inflammation/infection (transmigra-
tion), where they finally congregate and adhere to
extracellular matrix components such as laminin and
fibronectin. In the pulmonary capillaries however selectin-
mediated rolling of neutrophils does not occur, presumably
due to spatial constraints [76] and selectins are often even not
required during the acute response of neutrophils [77,78].Fig. 4. Summary of proposed pathophysiological links between defective/mutant C
lung disease. Defects in CFTR lead to abnormal airway surface liquid, altered s
mechanisms outlined, bacterial infection results and supports the vicious circle of o
mucociliary clearance and promotes chronic infection.Two different pathways have been described through
which neutrophils can emigrate in the alveoli and distal
bronchioles that are fed by the pulmonary circulation.
Neutrophils can emigrate through a pathway that requires
CD11/CD18 and one that does not require CD11/CD18 [79].
Neutrophil emigration in response to acute P. aeruginosa
exposure occurs through adhesion pathways that require
CD11/CD18. Via this pathway shedding of L-selectin only
occurs after the neutrophil has emigrated from the circulation
into the alveolar interstitium [80]. In contrast, chronic
Pseudomonas aeruginosa exposure shifts the migration
pathway to the CD11/CD18-independent route, and is
accompanied by a decrease in the number of neutrophils
migrating to the lung [81,82]. In this pathway L-selectin
shedding occurs in the vessels [80]. Neutrophils from both
CF and non-CF subjects showed similar upregulation of
CD11b, but CF neutrophils showed significantly less L-
selectin shedding than control subjects upon stimulation with
IL-8 or fMLP [83]. It has therefore been suggested that the
reduced L-selectin shedding observed in CF-patients may
reflect the maintenance of a heightened Facute-type_ (CD18-
dependent) response to P. aeruginosa.FTR, airway defence mechanisms and neutrophils in the development of CF
ubmucosal gland cell products and to abnormal neutrophil functions. Via
ngoing inflammation and infection in CF lung disease. This further impairs
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clinically stable CF-patients is increased [84]. Neutrophils
from acutely infected patients with CF however show
decreased chemotaxis, possibly due to bacterial exoprod-
ucts, and show lower numbers of IL-8 receptors [85,86].
Reduced responsiveness of CF neutrophils to IL-8 seems to
be associated with receptor desensitisation as a result of
exposure to high systemic levels of IL-8 and this might
contribute to the persistence of chronic endobronchial
infections [85,86].
2.8. Phagocytosis
Once neutrophils have transmigrated to the site of
infection phagocytosis can begin. This is a complex process
consisting of several morphological and biochemical steps.
After recognition and particle binding to the phagocyte
surface, ingestion (engulfment), phagosome origination,
phagolysosome formation (fusion of phagosome with
lysosomes), killing and degradation of ingested cells or
other material proceed. Antimicrobial efficiency of neutro-
phils is dependent on the generation of reactive oxygen
species (ROS) by assembly and activation of NADPH-
oxidase. Activation of the oxidative metabolism, known as
the respiratory burst first involves NADPH-oxidase, an
enzymatic complex that generates superoxide anion (O2
)
which can dismutate in H2O2. Generation of O2
 leads to
production of various reactive oxidants, including halogen-
ated oxidants generated through the myeloperoxidase (MPO)
pathway. MPO, an enzyme contained in azurophilic granules
of neutrophils, catalyzes the H2O2-dependent oxidation of
chloride (Cl) to hypochlorous acid (HOCl).
In neutrophils many functional responses, including
triggering of secretion in azurophilic granules (containing
neutrophil elastase (NE) and MPO), oxidant production and
microbe killing, are pH dependent.
Intracellular pH in CF neutrophils after phorbol ester
activation is more acidic, indicating an intrinsic defect in CF
neutrophil pH regulation possibly linked to mutant CFTR
[87]. This ‘‘hyperacidification’’ has also been described in
trans-Golgi network in CF lung epithelial cells [88].
Neutrophils of both CF homozygotes and heterozygotes
display normal NADPH activity but increased myeloperox-
idase-dependent oxidant activity [89].
CF neutrophils also release increased amounts of neu-
trophil elastase in response to TNF-a and IL-8 [90]. NE
plays a major role in the pathophysiology of chronic
inflammation in CF [91,92]. It directly contributes to tissue
damage by degrading structural proteins, such as elastin,
collagen, and proteoglycans, and has many other detrimental
biological activities in the CF airways. NE enhances macro-
molecular secretion from serous gland cells and promotes
hypertrophy and hyperplasia of the mucus-secreting appara-
tus and inhibits ciliary beating in vitro. NE also facilitates the
persistence of infection by cleaving immunoglobulins,
complement components and opsonin receptors, such asCR1, on the surface of phagocytes, and thus has an important
impact on opsonophagocytosis [93]. These effects may
further impair mucociliary and bacterial clearance and
exacerbate airway obstruction in CF-patients.
2.9. Apoptosis
After the successful elimination of an invading pathogen,
the inflammatory response should come to an end in order to
avoid further tissue damage. Therefore, neutrophils ulti-
mately are removed by apoptosis. CF pathogens like P.
aeruginosa and S. aureus stimulate epithelial expression of
G-CSF and GM-CSF, thereby counteracting induction of
apoptosis and thus prolonging the inflammatory response
[94]. The hyperacidification of CF cells as mentioned above
also has an anti-appoptotic effect [95].
In summary there is a complex pathophysiological
cascade leading to lung damage in CF, as summarized in
Fig. 4. The resultant excessive inflammatory response not
only fails to clear infection, but contributes to its persistence
and is mostly responsible for lung damage and the
progression of CF lung disease. Next to keeping control over
the infections, it is therefore probably equally important to
keep control over the (pulmonary) inflammation in CF.Acknowledgement
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